680 related articles for article (PubMed ID: 19607771)
21. Unusual hypersensitivity to warfarin in a critically ill patient.
Konishi H; Eguchi Y; Fujii M; Saotome T; Sasaki T; Takahashi K; Sudo M; Morii H; Minouchi T; Yamaji A
J Clin Pharm Ther; 2004 Oct; 29(5):485-90. PubMed ID: 15482394
[TBL] [Abstract][Full Text] [Related]
22. Warfarin-induced bleeding complications - clinical presentation and therapeutic options.
Wiedermann CJ; Stockner I
Thromb Res; 2008; 122 Suppl 2():S13-8. PubMed ID: 18549907
[TBL] [Abstract][Full Text] [Related]
23. Management of excessive anticoagulation or bleeding.
Makris M
Semin Vasc Med; 2003 Aug; 3(3):279-84. PubMed ID: 15199461
[TBL] [Abstract][Full Text] [Related]
24. Assessment of anticoagulation intensity and management of bleeding with old and new oral anticoagulants.
Liew A; Eikelboom JW; O'Donnell M; Hart RG
Can J Cardiol; 2013 Jul; 29(7 Suppl):S34-44. PubMed ID: 23790596
[TBL] [Abstract][Full Text] [Related]
25. Reversal of overanticoagulation in very elderly hospitalized patients with an INR above 5.0: 24-hour INR response after vitamin K administration.
Pautas E; Peyron I; Bouhadiba S; Golmard JL; Gouronnec A; Oboa N; Siguret V; Gouin-Thibault I
Am J Med; 2011 Jun; 124(6):527-33. PubMed ID: 21605730
[TBL] [Abstract][Full Text] [Related]
26. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature.
Leissinger CA; Blatt PM; Hoots WK; Ewenstein B
Am J Hematol; 2008 Feb; 83(2):137-43. PubMed ID: 17729241
[TBL] [Abstract][Full Text] [Related]
27. Practical application of the 10-mg warfarin initiation nomogram.
Wells PS; Le Gal G; Tierney S; Carrier M
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):403-8. PubMed ID: 19521238
[TBL] [Abstract][Full Text] [Related]
28. Treatment of warfarin-associated coagulopathy with vitamin K.
Patriquin C; Crowther M
Expert Rev Hematol; 2011 Dec; 4(6):657-65; quiz 666-7. PubMed ID: 22077529
[TBL] [Abstract][Full Text] [Related]
29. Probable interaction between warfarin and marijuana smoking.
Yamreudeewong W; Wong HK; Brausch LM; Pulley KR
Ann Pharmacother; 2009 Jul; 43(7):1347-53. PubMed ID: 19531696
[TBL] [Abstract][Full Text] [Related]
30. Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10.
Gunther KE; Conway G; Leibach L; Crowther MA
Thromb Res; 2004; 113(3-4):205-9. PubMed ID: 15140584
[TBL] [Abstract][Full Text] [Related]
31. Low-dose vitamin K to augment anticoagulation control.
Reese AM; Farnett LE; Lyons RM; Patel B; Morgan L; Bussey HI
Pharmacotherapy; 2005 Dec; 25(12):1746-51. PubMed ID: 16305294
[TBL] [Abstract][Full Text] [Related]
32. Warfarin induced coagulopathy in children: assessment of a conservative approach.
Bauman ME; Black K; Bauman ML; Kuhle S; Bajzar L; Massicotte MP
Arch Dis Child; 2011 Feb; 96(2):164-7. PubMed ID: 21068076
[TBL] [Abstract][Full Text] [Related]
33. Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding.
Stewart WS; Pettit H
Am J Emerg Med; 2013 Aug; 31(8):1251-4. PubMed ID: 23763937
[TBL] [Abstract][Full Text] [Related]
34. Analysis of inpatient use of fresh frozen plasma and other therapies and associated outcomes in patients with major bleeds from vitamin K antagonism.
Magee G; Peters C; Zbrozek A
Clin Ther; 2013 Sep; 35(9):1432-43. PubMed ID: 23954093
[TBL] [Abstract][Full Text] [Related]
35. Clinical experience with oral versus intravenous vitamin K for warfarin reversal.
Meehan R; Tavares M; Sweeney J
Transfusion; 2013 Mar; 53(3):491-8; quiz 490. PubMed ID: 22738309
[TBL] [Abstract][Full Text] [Related]
36. [Warfarin treatment and bleeding].
Breen AB; Vaskinn TE; Reikvam A; Skovlund E; Lislevand H; Madsen S
Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1835-7. PubMed ID: 12830257
[TBL] [Abstract][Full Text] [Related]
37. Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial.
Crowther MA; Julian J; McCarty D; Douketis J; Kovacs M; Biagoni L; Schnurr T; McGinnis J; Gent M; Hirsh J; Ginsberg J
Lancet; 2000 Nov; 356(9241):1551-3. PubMed ID: 11075768
[TBL] [Abstract][Full Text] [Related]
38. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
Knudsen JF; Sokol GH
Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
[TBL] [Abstract][Full Text] [Related]
39. Reversal of vitamin K antagonist-associated coagulopathy: a survey of current practice.
Neal M; Crowther M; Douketis J; Verhovsek M; Stidley C; Garcia D
Thromb Res; 2008; 122(6):864-6. PubMed ID: 18678398
[No Abstract] [Full Text] [Related]
40. Short-term warfarin reversal for elective surgery--using low-dose intravenous vitamin K: safe, reliable and convenient*.
Burbury KL; Milner A; Snooks B; Jupe D; Westerman DA
Br J Haematol; 2011 Sep; 154(5):626-34. PubMed ID: 21751986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
